John Smyth is Emeritus Professor of Medical Oncology in the University of Edinburgh, where his major research interest has been the development and evaluation of new anti-cancer drugs.
He has published over 350 papers and is past Editor-in-Chief of the European Journal of Cancer.
He served for several years on the UK Committee on Safety of Medicines; currently Chair’s the Expert Advisory Group for Oncology & Haematology for the Commission on Human Medicines and has served on the Scientific Advisory Group for Oncology to the EMEA.
He is a fellow of the Royal College of Physicians of Edinburgh and London, and fellow of the Royal Society of Edinburgh.
He is a past-president of the European Society of Medical Oncology and was from 2005 – 2007 President of the Federation of European Cancer Societies.